These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21148037)

  • 1. IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection.
    Racine R; McLaughlin M; Jones DD; Wittmer ST; MacNamara KC; Woodland DL; Winslow GM
    J Immunol; 2011 Jan; 186(2):1011-21. PubMed ID: 21148037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-driven induction of polyreactive IgM during intracellular bacterial infection.
    Jones DD; DeIulio GA; Winslow GM
    J Immunol; 2012 Aug; 189(3):1440-7. PubMed ID: 22730531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection.
    Racine R; Chatterjee M; Winslow GM
    J Immunol; 2008 Jul; 181(2):1375-85. PubMed ID: 18606692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired germinal center responses and suppression of local IgG production during intracellular bacterial infection.
    Racine R; Jones DD; Chatterjee M; McLaughlin M; Macnamara KC; Winslow GM
    J Immunol; 2010 May; 184(9):5085-93. PubMed ID: 20351185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The omentum is a site of protective IgM production during intracellular bacterial infection.
    Jones DD; Racine R; Wittmer ST; Harston L; Papillion AM; Dishaw LM; Randall TD; Woodland DL; Winslow GM
    Infect Immun; 2015 May; 83(5):2139-47. PubMed ID: 25776744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells.
    Foote JB; Mahmoud TI; Vale AM; Kearney JF
    J Immunol; 2012 Jan; 188(1):57-67. PubMed ID: 22116821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell activating factor inhibition impairs bacterial immunity by reducing T cell-independent IgM secretion.
    Jones DD; Jones M; DeIulio GA; Racine R; MacNamara KC; Winslow GM
    Infect Immun; 2013 Dec; 81(12):4490-7. PubMed ID: 24082070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.
    Thirumalapura NR; Stevenson HL; Walker DH; Ismail N
    Infect Immun; 2008 May; 76(5):1920-30. PubMed ID: 18285501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens.
    Habib S; El Andaloussi A; Hisham A; Ismail N
    PLoS One; 2016; 11(4):e0153223. PubMed ID: 27092553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis.
    Thirumalapura NR; Crossley EC; Walker DH; Ismail N
    Infect Immun; 2009 Dec; 77(12):5682-9. PubMed ID: 19805532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T-cell epitopes associated with protective immunity induced following vaccination of mice with an ehrlichial variable outer membrane protein.
    Nandi B; Hogle K; Vitko N; Winslow GM
    Infect Immun; 2007 Nov; 75(11):5453-9. PubMed ID: 17698576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection.
    Bitsaktsis C; Nandi B; Racine R; MacNamara KC; Winslow G
    Infect Immun; 2007 Oct; 75(10):4933-41. PubMed ID: 17664264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling.
    MacNamara KC; Oduro K; Martin O; Jones DD; McLaughlin M; Choi K; Borjesson DL; Winslow GM
    J Immunol; 2011 Jan; 186(2):1032-43. PubMed ID: 21149601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-1 cells in the bone marrow are a significant source of natural IgM.
    Choi YS; Dieter JA; Rothaeusler K; Luo Z; Baumgarth N
    Eur J Immunol; 2012 Jan; 42(1):120-9. PubMed ID: 22009734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early derivation of IgM memory cells and bone marrow plasmablasts.
    Papillion AM; Kenderes KJ; Yates JL; Winslow GM
    PLoS One; 2017; 12(6):e0178853. PubMed ID: 28575114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic extrafollicular reactions and BM plasma cells sustain IgM response associated with hypercholesterolemia.
    Khoo LH; Thiam CH; Soh SY; Angeli V
    Eur J Immunol; 2015 May; 45(5):1300-12. PubMed ID: 25639537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow.
    Reynolds AE; Kuraoka M; Kelsoe G
    J Immunol; 2015 Jan; 194(1):231-42. PubMed ID: 25429072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.
    Ghose P; Ali AQ; Fang R; Forbes D; Ballard B; Ismail N
    J Immunol; 2011 Aug; 187(3):1333-46. PubMed ID: 21715688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosis.
    Nandi B; Chatterjee M; Hogle K; McLaughlin M; MacNamara K; Racine R; Winslow GM
    Infect Immun; 2009 Oct; 77(10):4643-53. PubMed ID: 19635826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis.
    Zhang Y; Thai V; McCabe A; Jones M; MacNamara KC
    Infect Immun; 2014 Apr; 82(4):1698-709. PubMed ID: 24491580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.